We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Find out more
Instructor inspection copy request

E-book purchase
Choose a subscription

Downloaded copy on your device does not expire. Includes 4 years of Bookshelf Online.

close

Where applicable, tax will be added to the above price prior to payment.

E-book purchasing help

E-book purchase

E-books are granted under the terms of a single-user, non-transferable license, and may be accessed online from any location.

Contact information
E: Contact Us

Cover

Psychopharmacology

Fourth Edition

Jerry Meyer

Publication Date - 25 May 2022

ISBN: 9781605359878

816 pages
Hardcover
8.5â x 10.875â inches

In Stock

Unique in its breadth of coverage ranging from historical accounts of drug use to clinical and preclinical behavioral studies, Psychopharmacology is appropriate for undergraduates studying the relationships between the behavioral effects of psychoactive drugs and their mechanisms of action.

Description

Unique in its breadth of coverage ranging from historical accounts of drug use to clinical and preclinical behavioral studies, Psychopharmacology is appropriate for undergraduates studying the relationships between the behavioral effects of psychoactive drugs and their mechanisms of action.

Meyer's, Psychopharmacology enhanced ebook provide engaging features like self-study questions, and clinical case studies, cutting edge research, and applied pharmacology to keep students focused on the content, while providing the scientific depth, breadth, and rigor required for the course.

New to this Edition

  • NEW Enhanced e-Book with self-Assessment questions, animations, flashcards, and more!
  • NEW Learning Objectives
  • Critical thinking/active learning case studies that integrate concepts
  • Chapters 1 and 2: New Case Study Boxes link pharmacology and neuroscience to clinical practices
  • Chapter 3: Expanded coverage of oxytocin including use in treating autism disorders
  • Chapter 4: New techniques including genetic engineering and AI, and how they are used
  • Chapters 5-8: These chapters are about neurotransmitter systems. New emphasis in these chapters on clinical applications of drugs that target neurotransmitters
  • Chapter 9: New theories and mechanisms of drug addiction
  • Chapters 10-17: All on different recreational drugs
  • Chapter 11: Updated coverage of the opioid epidemic and treatments
  • Chapter 13: More coverage of cigarettes and vaping
  • Chapter 14: New coverage of cannabis legalization and therapeutic applications of CBD
  • Chapter 15: New coverage of psychedelic drugs and use in treatment of mood and trauma related disorders
  • Chapters 16-20: On neurobiology of neuropsychiatric and neurodegenerative disorders and the drugs used to treat them
  • Chapters 17 and 18: On classis pharmacotherapies, but also NEW coverage of use of non- traditional substances (like LSD) in treatment
  • Chapter 19: New treatment possibilities for schizophrenia are covered
  • Chapter 20: Covers new trial, therapies, tools, etc. for all neurodegenerative disorders, including coverage of emerging new systems that can be used for diagnosis

Features

  • Enhanced ebook with integrated animations, web-links, flashcards, and self-assessment questions
  • Chapter-opening vignettes foster student engagement.
  • Up-to-date and outstanding coverage of current research.
  • Breakout boxes present novel, and, in some cases, controversial topics for special discussion.
  • Box themes include History of Psychopharmacology; Pharmacology in Action; Clinical Applications; Of Special Interest; and The Cutting Edge
  • The book is extensively illustrated with full-color photographs and line art depicting important concepts and experimental data
  • Section Summaries highlight key concepts from the section of text just read
  • Chapter-ending Recommended Readings offer suggestions for further study
  • Enhanced e-Book provides an interactive learning pathway through the content
  • End-of-chapter study questions to further aid students

About the Author(s)

Jerrold S. Meyer is Professor Emeritus of Psychology and former Director of the interdeparmental Neuroscience and Behavior Program at the University of Massachusetts, Amherst.

Andrew M. Farrar is a Lecturer in the College of Natural Sciences at the University of Massachusetts Amherst and previously worked as a research scientist in academia and the pharmaceutical industry.

Dominik Biezonski is a Senior Scientist in Preclinical Development at Prevail Therapeutics, which focuses on developing gene therapies for neurodegenerative diseases.

Jennifer R. Yates is the Assistant Provost for Faculty Development, Teaching, & Learning, Director of the Center for Faculty Excellence, and Professor of Psychological Science at Lander University

Table of Contents

    Chapter 1. Principles of Pharmacology
    Chapter 2. Structure and Function of the Nervous System
    Chapter 4. Methods of Research in Psychopharmacology
    Chapter 5. Catecholamines
    Chapter 6. Serotonin
    Chapter 7. Acetylcholine
    Chapter 8. Glutamate and GABA
    Chapter 9. Drug Abuse and Addiction
    Chapter 10. Alcohol
    Chapter 11. The Opioids
    Chapter 12. Psychomotor Stimulants: Cocaine, Amphetamine, and Related Drugs
    Chapter 13. Nicotine and Caffeine
    Chapter 14. Marijuana and the Cannabinoids
    Chapter 15. Hallucinogens, PCP, and Ketamine
    Chapter 16. Inhalants, GHB, and Anabolic-Androgenic Steroids
    Chapter 17. Disorders of Anxiety and Impulsivity and the Drugs Used to Treat These Disorders
    Chapter 18. Affective Disorders: Antidepressants and Mood Stabilizers
    Chapter 19. Schizophrenia: Antipsychotic Drugs
    Chapter 20. Neurodegenerative Diseases, by Jennifer R. Yates, Lander University

Related Titles